Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors

BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR)–targeted tyrosine kinase inhibitors (TKIs) are the first-line therapy for EGFR-mutant non-small-cell lung cancer (NSCLC). Early prediction of treatment failure in patients with brain metastases treated with EGFR–TKIs may help in makin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting-Wei, Chao, Heng-Sheng, Chiu, Hwa-Yen, Lu, Chia-Feng, Liao, Chien-Yi, Lee, Yen, Chen, Jyun-Ru, Shiao, Tsu-Hui, Chen, Yuh-Min, Wu, Yu-Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689936/
https://www.ncbi.nlm.nih.gov/pubmed/37984256
http://dx.doi.org/10.1016/j.tranon.2023.101826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689936/
https://www.ncbi.nlm.nih.gov/pubmed/37984256
http://dx.doi.org/10.1016/j.tranon.2023.101826

Ejemplares similares